Chowell, D. (2018). Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy. American Association for the Advancement of Science (AAAS).
Chicago Style (17th ed.) CitationChowell, D. Patient HLA Class I Genotype Influences Cancer Response to Checkpoint Blockade Immunotherapy. American Association for the Advancement of Science (AAAS), 2018.
MLA (9th ed.) CitationChowell, D. Patient HLA Class I Genotype Influences Cancer Response to Checkpoint Blockade Immunotherapy. American Association for the Advancement of Science (AAAS), 2018.
Warning: These citations may not always be 100% accurate.